2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)200mg

tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate, 95.0%, 250mg

2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)ethanamine hydrochloride, 95%, 100mg

Thymolphthalein Complexone, pa, 25 g, envase de vidrio

(2-{[2-(4-Fluorophenyl)-1H-indol-3-yl]thio}ethyl)amine, 95.0%, 500mg

N-(2-Bromoethyl)phthalimide>98.0%(GC)(T)100g

Dimethyl [2,2'-bipyridine]-3,3'-dicarboxylate, 95.0%, 100mg

9-[(2S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one, 98.0%, 25g

CRGDS Peptide Hydrochloride>85.0%(HPLC)10mg

3-Methylmandelic acid, 98.0%, 10g

6-Bromo[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one, 97.0%, 250mg

3-(4-carboethoxyphenyl)-2-methyl-1-propene, 97.0%, 2g

250 ml vaso de cuello estrecho marrón GL 32 cuadrado